Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Currently, there are more companies enter into POC Diagnostics industry in the world, especially in USA. The main market players are, Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, etc.
Alere is the largest supplier of POC Diagnostics, with the revenue market share about 18% in 2015, and the top 6 supplier of POC Diagnostics, with the revenue market share about 68% in 2015. That is to say, the industry of POC Diagnostics is relative concentration.
There are nine kinds of POC Diagnostics, which are Blood Glucose Testing, Infectious Diseases Testing, ...
Table of Contents
2019-2024 Global POC Diagnostics Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global POC Diagnostics Consumption 2014-2024
2.1.2 POC Diagnostics Consumption CAGR by Region
2.2 POC Diagnostics Segment by Type
2.2.1 Blood Glucose Testing
2.2.2 Infectious Diseases Testing
2.2.3 Cardiac Markers Testing
2.2.4 Coagulation Testing
2.2.5 Pregnancy and Fertility Testing
2.2.6 Blood Gas/Electrolytes Testing
2.2.7 Tumor Markers Testing
2.2.8 Urinalysis Testing
2.2.9 Cholesterol Testing
2.3 POC Diagnostics Consumption by Type
2.3.1 Global POC Diagnostics Consumption Market Share by Type (2014-2019)
2.3.2 Global POC Diagnostics Revenue and ...